🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Evaluate the safety and tolerability of VX-659 in healthy subjects...
Status
Completed
Location
Multiple Locations
Start Date
2016-11
Trial ID
NCT03029455
Treatments Being Tested
The study is a Phase 2 Study to establish the safety and efficacy of a drug...
Status
Completed
Location
UAB Lung Health Center
Start Date
2017-03-16
Trial ID
NCT03085485
Treatments Being Tested
To evaluate the clinical mechanisms of action in lung and extrapulmonary sy...
Status
Completed
Location
Multiple Locations
Start Date
2016-02
Trial ID
NCT02508207
Treatments Being Tested
This is a Phase 2, randomized, double-blind, placebo- and tezacaftor/ivacaf...
Status
Completed
Location
Yale New Haven Hospital
Start Date
2017-08-08
Trial ID
NCT03224351
The primary objective of the study was to evaluate the efficacy of lumacaft...
Status
Completed
Location
Multiple Locations
Start Date
2013-04
Trial ID
NCT01807949
Treatments Being Tested
This study is designed to evaluate the effect of multiple doses of lumacaft...
Status
Completed
Location
Multiple Locations
Start Date
2013-06
Trial ID
NCT01910415
Treatments Being Tested
This is a Phase 2, randomized, double blind, placebo and active-controlled,...
Status
Completed
Location
Multiple Locations
Start Date
2016-11
Trial ID
NCT02951195
To evaluate the efficacy and safety of lumacaftor in combination with ivaca...
Status
Completed
Location
Multiple Locations
Start Date
2015-07
Trial ID
NCT02514473
This study will explore the impact of lumacaftor/ivacaftor (LUM/IVA) on dis...
Status
Completed
Location
Charite Paediatric Pulmonology Department
Start Date
2018-08-10
Trial ID
NCT03625466
The objective of this study was to evaluate the safety and efficacy of VX-6...
Status
Completed
Location
Multiple Locations
Start Date
2014-03
Trial ID
NCT02070744
Treatments Being Tested